ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $558,000 | -9.4% | 381,953 | -12.0% | 0.00% | -100.0% |
Q4 2016 | $616,000 | -21.7% | 434,153 | -3.4% | 0.00% | 0.0% |
Q3 2016 | $787,000 | +2.3% | 449,653 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $769,000 | -13.2% | 449,653 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $886,000 | +3.7% | 449,653 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $854,000 | -0.6% | 449,653 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $859,000 | -58.9% | 449,653 | -0.1% | 0.00% | -50.0% |
Q2 2015 | $2,089,000 | +6.2% | 450,133 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,967,000 | +21.3% | 450,133 | -3.7% | 0.00% | +100.0% |
Q4 2014 | $1,622,000 | -17.2% | 467,433 | 0.0% | 0.00% | -50.0% |
Q3 2014 | $1,959,000 | -28.5% | 467,433 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $2,739,000 | -7.0% | 467,433 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $2,945,000 | +21.7% | 467,433 | +13.0% | 0.00% | +50.0% |
Q4 2013 | $2,420,000 | -0.6% | 413,695 | -10.5% | 0.00% | 0.0% |
Q3 2013 | $2,435,000 | -31.9% | 462,085 | -0.6% | 0.00% | -50.0% |
Q2 2013 | $3,578,000 | – | 464,652 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |